Curis Lifesciences Limited (NSE:CURIS)

India · Delayed Price · Currency is INR

179.65

-4.15 (-2.26%)

At close: Nov 9, 2026

Market Cap	1.45B
Revenue (ttm)	606.29M +155.3%
Net Income	68.81M +1,304.6%
EPS	37.14 +4,048.1%
Shares Out	8.08M
PE Ratio	4.84
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,000
Open	184.50
Previous Close	183.80
Day's Range	179.00 - 184.50
52-Week Range	83.60 - 234.75
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 4, 2026

About Curis Lifesciences

Curis Lifesciences Limited engaged in the development, manufacturing and distribution of pharmaceutical products in India. It offers wide range of pharmaceutical products, such as tablets, capsules, oral liquid, and sterile ophthalmic ointments, as well as external preparations such as creams, gels, and ointments. The company's business model operates through loan licensing, contract manufacturing and own-brand marketing arrangements. Curis Lifesciences Limited was founded in 2010 and is based in Ahmedabad, India. [Read more]

Industry Commercial Physical and Biological Research

Founded 2010

Employees 86

Stock Exchange National Stock Exchange of India

Ticker Symbol CURIS

Full Company Profile

Financial Performance

In fiscal year 2026, Curis Lifesciences's revenue was 606.29 million, an increase of 20.63% compared to the previous year's 502.59 million. Earnings were 68.81 million, an increase of 10.87%.

Financial Statements